What is chemotherapy dense on dose?

Chemotherapy, or chemo, is a type of cancer treatment in which drugs are used to attack cancer cells. Traditionally, doses of chemotherapy are administered every three or four weeks, but chemotherapy reduces tumors and smaller tumors grow faster. Chemotherapy with a dense dose is administered more often than usual, so that more of these rapidly dividing tumor cells will catch. Chemotherapy drugs affect healthy cells and cancer cells, and at least three weeks between treatments were considered necessary to prevent too many white blood cells that fight infection. The dose chemotherapy overcomes this problem by giving patients medication to increase blood cell production. White blood cells are part of the immune system and are necessary to protect the body from infection. If white cells drop too low, patients become vulnerable infection, wipotentially fatal results. This difficulty reduced the minimum period between chemotherapy to three or four weeks, which reduced the total quantityHe knows drugs that can be administered at a given time.

dense dose chemotherapy allows a larger total amount of drug to be administered, which may be more effective in the treatment of some cancers. Growth factors that increase the production of white blood cells are administered along chemotherapy by a dense dose. Other side effects may still occur, and some patients in chemosmots at the dose have been reduced. The red blood cells have been reduced. There were also reports of bone pain, which can be associated with the use of growth factors.

Not all types of cancer respond to the treatment of chemotherapy with a dense dose. It seems beneficial for patients who have a type of breast cancer referred to as hormonal receptor-negative. AROUND 25 percent of all breast cancer cases are found to be hormonal receptor-negative. It seems that there is no clear benefit in using chemotherapy for dose for cancer patientsbreast with hormone receptor.

Future research could help determine whether a dense dose regime should be used for all breast cancer patients or whether it would be more suitable for certain groups. A study examining the use of chemotherapy on dose for other cancer, such as lymphomas and ovarian tumors, has also shown mixed results. It is possible that some patients may benefit and ongoing studies can help identify which of them.